Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology
Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the accumulation of protein aggregates (namely Lewy bodies) in dopaminergic neurons in the substantia nigra region of the brain. Alpha-synuclein (α-syn) is the major component of Lewy bodies in PD pat...
Saved in:
Main Authors: | Ning-Ning Yuan (Author), Cui-Zan Cai (Author), Ming-Yue Wu (Author), Qi Zhu (Author), HuanXing Su (Author), Min Li (Author), JiaoYan Ren (Author), Jie-Qiong Tan (Author), Jia-Hong Lu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
by: He X, et al.
Published: (2022)
by: He X, et al.
Published: (2022)
Similar Items
-
Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
by: Zhongyan Zhang, et al.
Published: (2023) -
Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017) -
Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014) -
CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?
by: Diana Perez-SanJose, et al.
Published: (2021) -
Modeling Parkinson's Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020)